Graham McLean has financial and commercial experience within the medical technology sector. He also has an understanding of North America and UK listed entities having worked in finance and operations roles for international companies.
He has worked with NYSE-listed Stryker for 16-years and has medical device and healthcare experience. At Stryker, Mr McLean held several senior positions including as president for Japan, Australia/New Zealand and Asia Pacific when he was based in Singapore and Hong Kong. Mr McLean was also responsible for transforming Asia Pacific, including restructuring their China distribution. Prior to Stryker, Mr McLean held senior finance and operational roles in Asia and Europe including international consumer brands Lion Nathan, Smiths Snackfoods (Pepsi), McVities (United Biscuits), United Distillers (Guinness) and Unilever.
He is an advisor to Bain & Company and GLG, and a board member of Suicide Prevention Australia.
Mr McLean holds a Bachelor of Science Geography from Durham University, is a CPA, a Fellow of The Chartered Institute of Management Accountants, and a graduate of the Australian Institute of Company Directors.
